Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02883062
Recruitment Status : Suspended (Other - Amendment pending to replace non-evaluable pts)
First Posted : August 30, 2016
Last Update Posted : February 6, 2019
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : May 17, 2019
  Estimated Study Completion Date : May 17, 2019